Proteomic Aging Clocks Enter the Clinic in Landmark Phase 2a Geroprotection Trial
Proteomic aging clocks have been integrated into a phase 2a clinical trial, enabling simultaneous assessment of geroprotective effects within an ...
Proteomic aging clocks have been integrated into a phase 2a clinical trial, enabling simultaneous assessment of geroprotective effects within an ...
A real-time Delphi study of French and Canadian experts finds widespread concern over the reliability, utility and legitimacy of direct-to-consumer ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine